Referências

1. Acharya, C., Dharel, N., Sterling, R.K., Chronic liver disease in the human immunodeficiency virus patient (2015) Clin Liver Dis, 19, pp. 1-22
2. Joshi, D., O'Grady, J., Dieterich, D., Gazzard, B., Agarwal, K., Increasing burden of liver disease in patients with HIV infection (2011) Lancet, 377, pp. 1198-1209
3. Merwat, S.N., Vierling, J.M., HIV infection and the liver: the importance of HCV-HIV coinfection and drug-induced liver injury (2011) Clin Liver Dis, 15, pp. 131-152
4. Puoti, M., Moioli, M.C., Travi, G., Rossotti, R., The burden of liver disease in human immunodeficiency virus-infected patients (2012) Semin Liver Dis, 32, pp. 103-113
5. Sulkowski, M.S., HCV-HIV co-infected patients: no longer a 'special' population? (2016) Liver Int, 36, pp. 43-46
6. (2015), http://www.unaids.org/sites/default/files/media_asset/AIDS_by_the_numbers_2015_en.pdf, AIDS by the numbers. UNAIDS. Geneva
7. Sherman, K.E., Peters, M., Koziel, M.J., HIV and liver disease forum: conference proceedings (2007) Hepatology, 45, pp. 1566-1577
8. Bica, I., McGovern, B., Dhar, R., Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection (2001) Clin Infect Dis, 32, pp. 492-497
9. Weber, R., Sabin, C.A., Friis-Moller, N., Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study (2006) Arch Intern Med, 166, pp. 1632-1641
10. Ofotokun, I., Smithson, S.E., Lu, C., Liver enzymes elevation and immune reconstitution among treatment-naive HIV-infected patients instituting antiretroviral therapy (2007) Am J Med Sci, 334, pp. 334-341
11. Akhtar, M.A., Mathieson, K., Arey, B., Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis (2008) Eur J Gastroenterol Hepatol, 20, pp. 1194-1204
12. Li, X.M., Jeffers, L.J., Reddy, K.R., Detection of HIV in liver tissue of AIDS patients by in situ hybridization (1989) Hepatology, 10, p. 678
13. Crane, M., Iser, D., Lewin, S.R., Human immunodeficiency virus infection and the liver (2012) World J Hepatol, 4, pp. 91-98
14. Quaresma, J.A., Barros, V.L., Pagliari, C., Hepatocyte lesions and cellular immune response in yellow fever infection (2007) Trans R Soc Trop Med Hyg, 101, pp. 161-168
15. Amato, V.S., de Andrade, H.F., Duarte, M.I., Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment (2003) Acta Trop, 85, pp. 39-49
16. Engwerda, C.R., Kaye, P.M., Organ-specific immune responses associated with infectious disease (2000) Immunol Today, 21, pp. 73-78
17. Raz, E., Organ-specific regulation of innate immunity (2007) Nat Immunol, 8, pp. 3-4
18. Unanue, E.R., Ito cells, stellate cells, and myofibroblasts: new actors in antigen presentation (2007) Immunity, 26, pp. 9-10
19. Cappell, M.S., Schwartz, M.S., Biempica, L., Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus (1990) Am J Med, 88, pp. 123-130
20. Cavicchi, M., Pialoux, G., Carnot, F., Value of liver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase (1995) Clin Infect Dis, 20, pp. 606-610
21. Prego, V., Glatt, A.E., Roy, V., Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients (1990) Arch Intern Med, 150, pp. 333-336
22. Moreno, A., Perez-Elias, M.J., Quereda, C., Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature (2006) Hum Pathol, 37, pp. 1344-1349
23. Albrecht, H., Redefining AIDS: towards a modification of the current AIDS case definition (1997) Clin Infect Dis, 24, pp. 64-74
24. Szeto, O., Finkelstein, A., Wei, X.J., Aguero-Rosenfeld, M., Shi, Y., Leishmania amastigotes in the ascites of a HIV-positive patient (2014) Diagn Cytopathol, 42, pp. 428-430
25. Rouphael, N.G., Talati, N.J., Vaughan, C., Infections associated with haemophagocytic syndrome (2007) Lancet Infect Dis, 7, pp. 814-822
26. Sun, H.Y., Chen, M.Y., Fang, C.T., Hemophagocytic lymphohistiocytosis: an unusual initial presentation of acute HIV infection (2004) J Acquir Immune Defic Syndr, 37, pp. 1539-1540
27. Huang, D.B., Wu, J.J., Hamill, R.J., Reactive hemophagocytosis associated with the initiation of highly active antiretroviral therapy (HAART) in a patient with AIDS (2004) Scand J Infect Dis, 36, pp. 516-519
28. Verbsky, J.W., Grossman, W.J., Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives (2006) Ann Med, 38, pp. 20-31
29. Henter, J.I., Horne, A., Aricó, M., HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis (2007) Pediatr Blood Cancer, 48, pp. 124-131
30. Abdalian, R., Heathcote, E.J., Sclerosing cholangitis: a focus on secondary causes (2006) Hepatology, 44, pp. 1063-1074
31. Chen, X.M., Keithly, J.S., Paya, C.V., Cryptosporidiosis (2002) N Engl J Med, 346, pp. 1723-1731
32. Benhamou, Y., Caumes, E., Gerosa, Y., AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients (1993) Dig Dis Sci, 38, pp. 1113-1118
33. Rosenberg, P.M., Farrell, J.J., Abraczinskas, D.R., Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus in HIV coinfection (2002) Am J Gastroenterol, 97, pp. 478-483
34. Ko, W.F., Cello, J.P., Rogers, S.J., Lecours, A., Prognostic factors for the survival of patients with AIDS cholangiopathy (2003) Am J Gastroenterol, 98, pp. 2176-2181
35. Sterling, R.K., Contos, M.J., Smith, P.G., Steatohepatitis: risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection (2008) Hepatology, 47, pp. 1118-1127
36. Sterling, R.K., Smith, P.G., Brunt, E.M., Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse (2013) J Clin Gastroenterol, 47, pp. 182-187
37. Morse, C.G., McLaughlin, M., Matthews, L., Nonalcoholic steatohepatitis and hepatic fibrosis in HIV-1-monoinfected adults with elevated aminotransferase levels on antiretroviral therapy (2015) Clin Infect Dis, 15 (60), pp. 1569-1578
38. Sherman, K.E., Rouster, S.D., Chung, R.T., Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group (2002) Clin Infect Dis, 34, pp. 831-837
39. Benhamou, Y., Bochet, M., Di Martino, V., Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group (1999) Hepatology, 30, pp. 1054-1058
40. Allory, Y., Charlotte, F., Benhamou, Y., Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group (2000) Hum Pathol, 31, pp. 69-74
41. Morishima, C., Shuhart, M.C., Yoshihara, C.S., Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection (2007) J Infect Dis, 196. , 577-558
42. Benhamou, Y., Di Martino, V., Bochet, M., Factors affecting liver fibrosis in human immunodeficiency virus and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy (2001) Hepatology, 34, pp. 283-287
43. Thio, C.L., Seaberg, E.C., Skolasky, R., HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) (2002) Lancet, 360, pp. 1921-1926
44. Salmon-Ceron, D., Lewden, C., Morlat, P., Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol (2005) J Hepatol, 42, pp. 799-805
45. Soriano, V., Puoti, M., Bonacini, M., Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel (2005) AIDS, 19, pp. 221-240
46. Kuppermann, B.D., Petty, J.G., Richman, D.D., Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome (1993) Am J Ophthalmol, 115, pp. 575-582
47. Lucas, S., Update on the pathology of AIDS (2001) Intensive Crit Care Nurs, 17, pp. 155-166
48. Katano, H., Hishima, T., Mochizuki, M., The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan (2014) BMC Infect Dis, 14, p. 229
49. McCormack, S., Walsh, J.C., Barton, S.E., Herpes simplex (2004) Tratado de infectologia, pp. 547-565. , Atheneu, São Paulo, Brazil, R. Veronesi (Ed.)
50. Quinnan, G.V., Masur, H., Rook, A.H., Herpesvirus infections in the acquired immune deficiency syndrome (1984) JAMA, 252, pp. 72-77
51. Wiwanitkit, V., Causative agents of liver abscess in HIV-seropositive patients: a 10-year case series in Thai hospitalized patients (2005) Trop Doct, 35, pp. 115-117
52. Mastroianni, A., Coronado, O., Scarani, P., Liver toxoplasmosis and acquired immunodeficiency syndrome (1996) Recenti Prog Med, 87, pp. 353-355
53. Denk, H., Scheuer, P.J., Baptista, A., Guidelines for the diagnosis and interpretation of hepatic granulomas (1994) Histopathology, 25, pp. 209-218
54. Ishak, K., Granulomas in the liver (1995) Adv Pathol Lab Med, 8, p. 247
55. Lefkowitch, J.H., Hepatic granulomas (1999) J Hepatol, 30, pp. 40-45
56. Kleiner, D.E., Granulomas in the liver (2006) Semin Diagn Pathol, 23, pp. 161-169
57. Drebber, U., Kasper, H.U., Ratering, J., Hepatic granulomas: histological and molecular pathological approach to differential diagnosis-a study of 442 cases (2008) Liver Int, 28, pp. 828-834
58. Lamps, L.W., Hepatic granulomas: a review with emphasis on infectious causes (2015) Arch Pathol Lab Med, 139, pp. 867-875
59. Gandhi, N.R., Moll, A., Sturm, A.W., Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa (2006) Lancet, 368, pp. 1575-1580
60. Yew, W.W., Leung, C.C., Update in tuberculosis 2007 (2008) Am J Respir Crit Care Med, 177, pp. 479-485
61. Farhi, D.C., Mason, U.G., Horsburgh, C.R., Pathologic findings in disseminated Mycobacterium avium-intracellulare infection (1986) Am J Clin Pathol, 85, pp. 67-72
62. Jones, R., Dunning, J., Nelson, M., HIV and hepatitis C co-infection (2005) Int J Clin Pract, 59, pp. 1082-1087
63. Klatt, E.C., Jensen, D.F., Meyer, P.R., Pathology of Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome (1987) Hum Pathol, 18, pp. 709-714
64. Riddell, J., Kaul, D.R., Karakousis, P.C., Mycobacterium avium complex immune reconstitution inflammatory syndrome: long term outcomes (2007) J Transl Med, 5, p. 50
65. Altamura, M., Casale, D., Pepe, M., Immune responses to fungal infections and therapeutic implications (2001) Curr Drug Targets Immune Endocr Metabol Disord, 1, pp. 189-197
66. Wheat, L.J., Small, C.B., Disseminated histoplasmosis in the acquired immune deficiency syndrome (1984) Arch Intern Med, 144, pp. 2147-2149
67. Antinori, S., Magni, C., Nebuloni, M., Histoplasmosis among human immunodeficiency virus infected people in Europe: report of 4 cases and review of the literature (2006) Medicine (Baltimore), 85, pp. 22-36
68. Levitz, S.M., The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis (1991) Rev Infect Dis, 13, pp. 1163-1169
69. Shibuya, K., Hirata, A., Omuta, J., Granuloma and cryptococcosis (2005) J Infect Chemother, 11, pp. 115-122
70. Mortele, K.J., Segatto, E., Ros, P.R., The infected liver: radiologic-pathologic correlation (2004) Radiographics, 24, pp. 937-955
71. Vanderveken, O.M., Colebunders, R.L., Collier, I., Successful iterative drainage and partial hepatectomy for pyogenic liver abscess in a HIV seropositive patient (2002) Acta Chir Belg, 102, pp. 59-62
72. Adinolfi, L.E., Gambardella, M., Andreana, A., Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity (2001) Hepatology, 33, pp. 1358-1364
73. (2006) Estimated prevalence of significant liver disease among 4,052 HIV-infected adults with and without chronic hepatitis B and C [abstract 842].13th Conference on Retroviruses and Opportunistic Infections
74. 2006 February 5-8, , Alexandria, VA Foundation for Retrovirology and Human Health, Denver, CO, M. Sulkowski, S. Mehta, R. Montes de Oca (Eds.)
75. Bonacini, M., Louie, S., Bzowej, N., Survival in patients with HIV infection and viral hepatitis B or C: a cohort study (2004) AIDS, 18, pp. 2039-2045
76. Barreiro, P., Martin-Carbonero, L., Nunez, M., Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3 (2006) Clin Infect Dis, 42, pp. 1032-1039
77. Nunez, M., Soriano, V., Hepatotoxicity of antiretrovirals: incidence, mechanisms and management (2005) Drug Saf, 28, pp. 53-66
78. Pérez-Matute, P., Pérez-Martínez, L., Blanco, J.R., Oteo, J.A., Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome (2013) Oxid Med Cell Longev, 2013, p. 493413
79. Maida, I., Nunez, M., Rios, M.J., Severe liver disease associated with prolonged exposure to antiretroviral drugs (2006) J Acquir Immune Defic Syndr, 42, pp. 177-182
80. Gallant, J.E., Moore, R.D., Richman, D.D., Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group (1992) J Infect Dis, 166, pp. 1223-1227
81. Dalton, H.R., Bendall, R.P., Keane, F.E., Persistent carriage of hepatitis E virus in patients with HIV infection (2009) N Engl J Med, 361, pp. 1025-1027
82. Mateos-Lindemann, M.L., Diez-Aguilar, M., Galdamez, A.L., Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain (2014) J Med Virol, 86, pp. 71-74
83. Mazigo, H.D., Dunne, D.W., Morona, D., Periportal fibrosis, liver and spleen sizes among S. mansoni mono or co-infected individuals with human immunodeficiency virus-1 in fishing villages along Lake Victoria shores, North-Western, Tanzania (2015) Parasit Vectors, 8, p. 260
84. Schmid, P., Bregenzer, A., Huber, M., Progression of liver fibrosis in HIV/HCV co-infection: a comparison between non-invasive assessment methods and liver biopsy (2015) PLoS One, p. 10
85. Tsokos, M., Erbersdobler, A., Pathology of peliosis (2005) Forensic Sci Int, 149, pp. 25-33
86. Yanoff, M., Rawson, A.J., Peliosis hepatis. An anatomic study with demonstration of two varieties (1964) Arch Pathol, 77, pp. 159-165
87. Gulubova, M., Immunohistochemical localization of collagen type III and type IV, laminin, tenascin and alpha-smooth muscle actin (alphaSMA) in the human liver in peliosis (2002) Pathol Res Pract, 198, pp. 803-812
88. Duarte, M.I., Oliveira, M.S., Lula, D., Diagnóstico etiológico da angiomatose bacilar por reação imunohistoquímica (1996) News Lab, 15, pp. 100-102
89. Slater, L.N., Pitha, J.V., Herrera, L., Rochalimaea henselae infection in acquired immunodeficiency syndrome causing inflammatory disease without angiomatosis or peliosis. Demonstration by immunocytochemistry and corroboration by DNA amplification (1994) Arch Pathol Lab Med, 118, pp. 33-38
90. Koehler, J.E., Bartonella-associated infections in HIV-infected patients (1995) AIDS Clin Care, 7, pp. 97-102
91. Pinti, M., Salomoni, P., Cossarizza, A., Anti-HIV drugs and the mitochondria (2006) Biochim Biophys Acta, 1757, pp. 700-707
92. Aggarwal, S., Fiel, M.I., Schiano, T.D., Obliterative portal venopathy: a clinical and histopathological review (2013) Dig Dis Sci, 58, pp. 2767-2776
93. Buckley, J.A., Hutchins, G.M., Association of hepatic veno-occlusive disease with the acquired immunodeficiency syndrome (1995) Mod Pathol, 8, pp. 398-401
94. Mallet, V., Blanchard, P., Verkarre, V., Vallet-Pichard, A., Fontaine, H., Lascoux-Combe, C., Pol, S., Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients (2007) AIDS, 21, pp. 187-192
95. Vispo, E., Moreno, A., Maida, I., Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings (2010) AIDS, 24, pp. 1171-1176
96. Blumenfeld, W., Egbert, B., Sagebiel, R.W., Differential diagnosis of Kaposi's sarcoma (1985) Arch Pathol Lab Med, 109, pp. 123-127
97. Cassidy, W.M., Govindarajan, S., Gupta, S., Influence of HIV on chronic hepatitis B and D infection (abstract 485) (1989) Hepatology, 10, p. 690
98. Essex, M., Kanki, P.J., HIV-2 (1994) Textbook of AIDS Medicine, pp. 873-886. , Williams & Wilkins, Baltimore, S. Broder (Ed.)
99. Favre, O., Heyraud, J.P., Chossegros, P., Influence of HIV infection on hepatitis B virus infection in homosexual patients (1989) Gastroenterol Clin Biol, 13, pp. 696-700
100. Foster, G.R., Ackrill, A.M., Goldin, R.D., Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA (1991) Proc Natl Acad Sci USA, 88, pp. 2888-2892
101. Mendes-Corrêa, M.C., Andrade, H.F., Fumica Takakura, C., Seixas Duarte, M.I., Hepatic ultrastructural mitochondrial changes prior to antiretroviral therapy in HIV-infected patients in Brazil (2008) J Int Assoc Physicians AIDS Care (Chic), 7, pp. 252-258
102. Fisher, K., Vuppalanchi, R., Saxena, R., Drug-induced liver injury (2015) Arch Pathol Lab Med, 139, pp. 876-887
103. Grulich, A.E., van Leeuwen, M.T., Falster, M.O., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis (2007) Lancet, 370, pp. 59-67
104. Grulich, A.E., Li, Y., McDonald, A., Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis (2002) AIDS, 16, pp. 1155-1161
105. Angeletti, P.C., Zhang, L., Wood, C., The viral etiology of AIDS-associated malignancies (2008) Adv Pharmacol, 56, pp. 509-557
106. Nasti, G., Martellotta, F., Berretta, M., Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome related Kaposi sarcoma (2003) Cancer, 98, pp. 2440-2446
107. Chang, Y., Cesarman, E., Pessin, M.S., Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma (1994) Science, 266, pp. 1865-1869
108. Gallafent, J.H., Buskin, S.E., De Turk, P.B., Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy (2005) J Clin Oncol, 23, pp. 1253-1260
109. Acharya, C., Dharel, N., Sterling, R.K., Chronic liver disease in the human immunodeficiency virus patient (2015) Clin Liver Dis, 19 (1), pp. 1-22
110. Huang, L.M., Chao, M.F., Chen, M.Y., Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1 (2001) J Biol Chem, 276, pp. 13427-13432
111. Barillari, G., Sgadari, C., Fiorelli, V., The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor (1999) Blood, 94, pp. 663-672
112. Hengge, U.R., Ruzicka, T., Tyring, S.K., Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy (2002) Lancet Infect Dis, 2, pp. 281-292
113. Ensoli, B., Sgadari, C., Barillari, G., Biology of Kaposi's sarcoma (2001) Eur J Cancer, 37, pp. 1251-1269
114. Guedes, F., de Andrade, H.F., Fernandes, E.R., The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals (2008) Br J Dermatol, 159, pp. 839-846
115. Feller, L., Lemmer, J., Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma (2008) Infect Agent Cancer, 3, p. 1
116. Douglas, J.L., Gustin, J.K., Dezube, B., Kaposi's sarcoma: a model of both malignancy and chronic inflammation (2007) Panminerva Med, 49, pp. 119-138
117. Ackerman, A.B., Subtle clues to diagnosis by conventional microscopy. The patch stage of Kaposi's sarcoma (1979) Am J Dermatopathol, 1, pp. 165-172
118. Harris, N.L., Jaffe, E.S., Diebold, J., World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 (1999) J Clin Oncol, (17), pp. 3835-3849
119. Carbone, A., Gloghini, A., AIDS-related lymphomas: from pathogenesis to pathology (2005) Br J Haematol, 130, pp. 662-670
120. Housset, C., Lamas, E., Brechot, C., Detection of HIV1 RNA and p24 antigen in HIV1-infected human liver (1990) Res Virol, 141, pp. 153-159
121. Uccini, S., Monardo, F., Ruco, L.P., High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease (1989) Lancet, 1, p. 1458
122. Cioc, A.M., Allen, C., Kalmar, J.R., Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8 (2004) Am J Surg Pathol, 28, pp. 41-46
123. Bozner, P., Elkhalifa, M.Y., Anaplastic large cell lymphoma of T-cell phenotype in acquired immunodeficiency syndrome (1997) South Med J, 90, pp. 559-566
124. Mounier, N., Spina, M., Gisselbrecht, C., Modern management of non-Hodgkin lymphoma in HIV infected patients (2007) Br J Haematol, 136, pp. 685-698
125. Levine, A.M., Hodgkin's disease in the setting of human immunodeficiency virus infection (1998) J Natl Cancer Inst Monogr, pp. 37-42
126. Grogg, K.L., Miller, R.F., Dogan, A., HIV infection and lymphoma (2007) J Clin Pathol, 60, pp. 1365-1372
127. Said, J.W., Immunodeficiency-related Hodgkin lymphoma and its mimics (2007) Adv Anat Pathol, 14, pp. 189-194
128. Carbone, A., Gloghini, A., Larocca, L.M., Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells (1999) Blood, 93, pp. 2319-2326
129. Carbone, A., Gloghini, A., Serraino, D., HIV-associated Hodgkin lymphoma (2009) Curr Opin HIV AIDS, 4, pp. 3-10